2021
DOI: 10.1016/j.envint.2021.106596
|View full text |Cite
|
Sign up to set email alerts
|

Associations of perfluorooctane sulfonate alternatives and serum lipids in Chinese adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 53 publications
1
5
1
Order By: Relevance
“…However, the relationship of human exposure and overweight/ obesity status is still controversial, given concerns about reverse causality and effective dose (Jain 2020). Due to different modeling approaches and inconsistent confounding variables, the results of some studies were not consistent with ours (Averina et Though there is no evidence that showed Cl-PFESAs might be potential obesogens in human beings, our previous epidemiologic studies found serum Cl-PFESAs concentrations were signi cantly positively associated with serum lipids (Cong et al 2021) and the risk of metabolic syndrome (MetS) (Yu et al 2021). In addition, Yao et al (Yao et al 2020) reported multivariate linear regression coe cients of 9.80% (95% CI: 6.09, 13.63) for cholesterol (mmol/L), 9.59% (95% CI: 5.29, 14.07) for low-density lipoprotein cholesterol (mmol/L), 12.34% (95% CI: 2.80, 2.88) for triglycerides (mmol/L), higher 6:2 Cl-PFESA per lnng/mL concentrations, respectively, which suggests potential elevated lipid parameters from exposure to 6:2 Cl-PFESA.…”
Section: Discussioncontrasting
confidence: 58%
“…However, the relationship of human exposure and overweight/ obesity status is still controversial, given concerns about reverse causality and effective dose (Jain 2020). Due to different modeling approaches and inconsistent confounding variables, the results of some studies were not consistent with ours (Averina et Though there is no evidence that showed Cl-PFESAs might be potential obesogens in human beings, our previous epidemiologic studies found serum Cl-PFESAs concentrations were signi cantly positively associated with serum lipids (Cong et al 2021) and the risk of metabolic syndrome (MetS) (Yu et al 2021). In addition, Yao et al (Yao et al 2020) reported multivariate linear regression coe cients of 9.80% (95% CI: 6.09, 13.63) for cholesterol (mmol/L), 9.59% (95% CI: 5.29, 14.07) for low-density lipoprotein cholesterol (mmol/L), 12.34% (95% CI: 2.80, 2.88) for triglycerides (mmol/L), higher 6:2 Cl-PFESA per lnng/mL concentrations, respectively, which suggests potential elevated lipid parameters from exposure to 6:2 Cl-PFESA.…”
Section: Discussioncontrasting
confidence: 58%
“…Previous research has also linked Cl-PFESAs to adverse birth outcomes, such as premature birth and low birth weight, as well as changes in vitamin D and hormone levels [20,[39][40][41]. Epidemiological evidence also suggested that Cl-PFESAs further affected adult health, including hypertension, thyroid hormone disturbances, dyslipidemia, and liver function abnormalities [42][43][44][45]. Thus, potential health risks should be considered when using these novel PFASs as substitutes.…”
Section: Discussionmentioning
confidence: 99%
“…62,87,111 Analysis of participants in the Isomers of C8 Project (China, 1238 participants) showed that both PFOA and PFOS were associated with total serum cholesterol and LDL-C but not HDL-C or triglycerides. 112 Cross-sectional analysis of a contaminated community in Laizhou Bay, China (162 participants), showed that PFOA (the predominant PFAS) was linked with total serum cholesterol and LDL-C but not HDL-C or triglycerides. 113 The PFAS Health study in Australia (1406 participants) analyzed participants living in 3 communities known to have PFAS-contaminated water.…”
Section: Dyslipidemia and Atherosclerosismentioning
confidence: 99%